A prospective cohort study on the safety of checkpoint inhibitors in older cancer patients - the ELDERS study.

Gomes, F; Lorigan, P; Woolley, S; Foden, P; Burns, K; Yorke, J; Blackhall, F

Gomes, F; Lorigan, P; Woolley, S; Foden, P; Burns, K; Yorke, J; Blackhall, F.

Affiliation

Gomes F; Medical Oncology Department, The Christie NHS Foundation Trust, Manchester, UK; Patient-Centred Research Centre, The Christie NHS Foundation Trust, Manchester, UK. Electronic address: fabio.gomes2@nhs.net.
Lorigan P; Medical Oncology Department, The Christie NHS Foundation Trust, Manchester, UK; Division of Medical Sciences, University of Manchester, Manchester, UK.
Woolley S; Research & Innovation Department, The Christie NHS Foundation Trust, Manchester, UK.
Foden P; Data Analytics Department, The Christie NHS Foundation Trust, Manchester, UK.
Burns K; Research & Innovation Department, The Christie NHS Foundation Trust, Manchester, UK.
Yorke J; Patient-Centred Research Centre, The Christie NHS Foundation Trust, Manchester, UK; Division of Nursing, Midwifery and Social Work, University of Manchester, Manchester, UK.
Blackhall F; Medical Oncology Department, The Christie NHS Foundation Trust, Manchester, UK; Division of Medical Sciences, University of Manchester, Manchester, UK.

ESMO Open ; 6(1): 100042, 2021 02.

Article in En | MEDLINE | ID: mdl-33516147

Subject(s)
Key words

ELDERS; G8; cancer; elderly; immunotherapy; toxicity

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Humans Language: En Journal: ESMO Open Year: 2021 Document type: Article Country of publication: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google